Prestige Consumer Healthcare Gross Profit Growth & History (PBH)
Prestige Consumer Healthcare's gross profit was $595.6M for fiscal 2026.
View full Prestige Consumer Healthcare company overviewPrestige Consumer Healthcare annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | $595.6M | −$38.9M | −6.13% |
| 2025 | 2025-03-31 | $634.5M | $10.0M | +1.60% |
| 2024 | 2024-03-31 | $624.4M | −$846,000 | −0.14% |
| 2023 | 2023-03-31 | $625.3M | $4.6M | +0.75% |
| 2022 | 2022-03-31 | $620.6M | $73.2M | +13.37% |
| 2021 | 2021-03-31 | $547.5M | −$4.8M | −0.86% |
| 2020 | 2020-03-31 | $552.2M | −$3.4M | −0.60% |
| 2019 | 2019-03-31 | $555.6M | −$20.9M | −3.63% |
| 2018 | 2018-03-31 | $576.5M | $76.2M | +15.24% |
| 2017 | 2017-03-31 | $500.3M | $33.1M | +7.08% |
| 2016 | 2016-03-31 | $467.2M | $61.0M | +15.01% |
| 2015 | 2015-03-31 | $406.2M | $70.7M | +21.06% |
| 2014 | 2014-03-31 | $335.6M | −$8.2M | −2.38% |
| 2013 | 2013-03-31 | $343.7M | $116.4M | +51.17% |
| 2012 | 2012-03-31 | $227.4M | $56.5M | +33.07% |
| 2011 | 2011-03-31 | $170.9M | $17.4M | +11.36% |
| 2010 | 2010-03-31 | $153.4M | — | — |
Prestige Consumer Healthcare quarterly gross profit
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-06-30 | $136.2M | −$4.1M | −2.95% |
| Q4 2026 | 2026-03-31 | $146.3M | −$23.7M | −13.95% |
| Q3 2026 | 2025-12-31 | $157.4M | −$3.7M | −2.29% |
| Q2 2026 | 2025-09-30 | $151.6M | −$5.8M | −3.69% |
| Q1 2026 | 2025-06-30 | $140.3M | −$5.7M | −3.90% |
| Q4 2025 | 2025-03-31 | $170.0M | $18.2M | +11.98% |
| Q3 2025 | 2024-12-31 | $161.0M | $3.1M | +1.97% |
| Q2 2025 | 2024-09-30 | $157.4M | −$2.6M | −1.65% |
| Q1 2025 | 2024-06-30 | $146.0M | −$8.7M | −5.59% |
| Q4 2024 | 2024-03-31 | $151.8M | −$1.9M | −1.27% |
| Q3 2024 | 2023-12-31 | $157.9M | $7.5M | +5.01% |
| Q2 2024 | 2023-09-30 | $160.0M | −$989,000 | −0.61% |
| Q1 2024 | 2023-06-30 | $154.7M | −$5.4M | −3.40% |
| Q4 2023 | 2023-03-31 | $153.8M | $4.9M | +3.29% |
| Q3 2023 | 2022-12-31 | $150.4M | −$4.7M | −3.00% |
| Q2 2023 | 2022-09-30 | $161.0M | $3.3M | +2.09% |
| Q1 2023 | 2022-06-30 | $160.1M | $1.1M | +0.70% |
| Q4 2022 | 2022-03-31 | $148.9M | $11.8M | +8.61% |
| Q3 2022 | 2021-12-31 | $155.1M | $16.2M | +11.64% |
| Q2 2022 | 2021-09-30 | $157.7M | $20.1M | +14.57% |
| Q1 2022 | 2021-06-30 | $159.0M | $25.1M | +18.78% |
| Q4 2021 | 2021-03-31 | $137.1M | −$6.9M | −4.76% |
| Q3 2021 | 2020-12-31 | $138.9M | $1.4M | +1.01% |
| Q2 2021 | 2020-09-30 | $137.7M | $910,000 | +0.67% |
| Q1 2021 | 2020-06-30 | $133.9M | −$199,000 | −0.15% |
| Q4 2020 | 2020-03-31 | $143.9M | $5.7M | +4.10% |
| Q3 2020 | 2019-12-31 | $137.5M | −$1.7M | −1.25% |
| Q2 2020 | 2019-09-30 | $136.8M | −$721,000 | −0.52% |
| Q1 2020 | 2019-06-30 | $134.1M | −$6.6M | −4.66% |
| Q4 2019 | 2019-03-31 | $138.2M | −$3.0M | −2.13% |
| Q3 2019 | 2018-12-31 | $139.2M | −$8.4M | −5.71% |
| Q2 2019 | 2018-09-30 | $137.5M | −$6.6M | −4.60% |
| Q1 2019 | 2018-06-30 | $140.6M | −$2.9M | −1.99% |
| Q4 2018 | 2018-03-31 | $141.3M | $11.1M | +8.51% |
| Q3 2018 | 2017-12-31 | $147.7M | $23.1M | +18.57% |
| Q2 2018 | 2017-09-30 | $144.1M | $20.1M | +16.24% |
| Q1 2018 | 2017-06-30 | $143.5M | $21.9M | +18.00% |
| Q4 2017 | 2017-03-31 | $130.2M | $11.9M | +10.09% |
| Q3 2017 | 2016-12-31 | $124.5M | $7.8M | +6.65% |
| Q2 2017 | 2016-09-30 | $124.0M | $4.0M | +3.36% |
| Q1 2017 | 2016-06-30 | $121.6M | $9.4M | +8.34% |
| Q4 2016 | 2016-03-31 | $118.3M | $8.2M | +7.43% |
| Q3 2016 | 2015-12-31 | $116.8M | $5.0M | +4.51% |
| Q2 2016 | 2015-09-30 | $119.9M | $17.4M | +16.97% |
| Q1 2016 | 2015-06-30 | $112.2M | $30.4M | +37.10% |
| Q4 2015 | 2015-03-31 | $110.1M | $31.2M | +39.62% |
| Q3 2015 | 2014-12-31 | $111.7M | $31.3M | +38.87% |
| Q2 2015 | 2014-09-30 | $102.5M | $9.3M | +10.00% |
| Q1 2015 | 2014-06-30 | $81.9M | −$1.2M | −1.39% |
| Q4 2014 | 2014-03-31 | $78.8M | −$9.2M | −10.48% |
| Q3 2014 | 2013-12-31 | $80.5M | −$4.5M | −5.33% |
| Q2 2014 | 2013-09-30 | $93.2M | $2.7M | +2.96% |
| Q1 2014 | 2013-06-30 | $83.0M | −$580,000 | −0.69% |
| Q4 2013 | 2013-03-31 | $88.1M | $19.6M | +28.59% |
| Q3 2013 | 2012-12-31 | $85.0M | $29.9M | +54.20% |
| Q2 2013 | 2012-09-30 | $90.5M | $36.6M | +67.97% |
| Q1 2013 | 2012-06-30 | $83.6M | $33.7M | +67.65% |
| Q4 2012 | 2012-03-31 | $68.5M | $22.2M | +47.91% |
| Q3 2012 | 2011-12-31 | $55.1M | $11.1M | +25.24% |
| Q2 2012 | 2011-09-30 | $53.9M | $11.3M | +26.57% |
| Q1 2012 | 2011-06-30 | $49.9M | $11.9M | +31.33% |
| Q4 2011 | 2011-03-31 | $46.3M | — | — |
| Q3 2011 | 2010-12-31 | $44.0M | — | — |
| Q2 2011 | 2010-09-30 | $42.6M | — | — |
| Q1 2011 | 2010-06-30 | $38.0M | — | — |
Prestige Consumer Healthcare gross profit trends
Over the last five fiscal years, Prestige Consumer Healthcare's gross profit increased from $547.5M to $595.6M, a change of $48.1M. The latest reported quarter, Q1 2027, shows $136.2M.
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Prestige Consumer Healthcare source filings ↗